SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-15-000195
Filing Date
2015-05-07
Accepted
2015-05-07 09:25:22
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT rgbp20150331form10q.htm 10-Q 288430
2 CONVERTIBLE PROMISSORY NOTE rgbp20150331form10qex10_1.htm EX-10.1 23878
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER rgbp20150331form10qex31_1.htm EX-31.1 9962
4 CERTIFICATION OF ACTING CHIEF FINANCIAL OFFICER rgbp20150331form10qex31_2.htm EX-31.2 9953
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER rgbp20150331form10qex32_1.htm EX-32.1 5652
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER rgbp20150331form10qex32_2.htm EX-32.2 5665
  Complete submission text file 0001607062-15-000195.txt   2163836

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE rgbp-20150331.xml EX-101.INS 203857
8 XBRL SCHEMA FILE rgbp-20150331.xsd EX-101.SCH 30920
9 XBRL CALCULATION FILE rgbp-20150331_cal.xml EX-101.CAL 27920
10 XBRL DEFINITION FILE rgbp-20150331_def.xml EX-101.DEF 14984
11 XBRL LABEL FILE rgbp-20150331_lab.xml EX-101.LAB 146677
12 XBRL PRESENTATION FILE rgbp-20150331_pre.xml EX-101.PRE 108653
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 15839748
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences